HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

6th Edition of World Congress on Infectious Diseases

June 24-26, 2024 | Paris, France

June 24 -26, 2024 | Paris, France
Infection 2022

Lester Jay T Corsame

Speaker at Infection Conferences - Lester Jay T Corsame
Philippine College of Physician, Philippines


The Philippines is one of the high tuberculosis burden countries and drug- resistance is widespread in the country and abroad and threatens the success of TB program. Timely and efficient MDRTD treatment is crucial in preventing disease transmission and reducing the morbidity and mortality. Review of literature showed disparate predictors of treatment outcome and only prevalence studies are available in the Philippines. Hence, the findings of this study can be different among Filipinos. This study aims to determine the predictors of treatment outcomes among drug-resistant patients in outpatient setting at Zamboanga City Medical Center TB DOTS Center to enhance the TB program and its outcome.

This study is a retrospective cohort analytical design, which was conducted at the TB DOTS Center of Zamboanga City Medical Center. Using the data registry book from January 2015 to December 2019, patient’s demographic, and clinical characteristics were reviewed, collected, tabulated and analysis was done using binary regression to determine the predictors of treatment outcomes among drug-resistant tuberculosis patients. Of the 207 DR-TB patients, only 176 were included in the analysis, 120 (68.2%) had successful treatment outcome while 56 (31.8%) had poor treatment outcome. Age less than 40 years (p value= 0.038), absence of diabetes (p value= 0.079) and susceptible to isoniazid (p value= 0.025) and streptomycin (p values=0.012) were predictors of good outcome while none of the variables were predictors of mortality. The common drug resistance pattern were Rifampicin-resistant (56.8%), followed by MDR TB (36.4%).

The common characteristics of drug-resistant tuberculosis are male sex, age more than 40 years old, married, living in urban areas and with history of previous TB treatment. None of the variables were predictors of mortality however, age less than 40 years old, absence of diabetes, TB strains susceptible to isoniazid and streptomycin were predictors of good outcome.
Drug resistant, treatment outcomes, MDR-TB, treatment success, poor outcomes MESH WORDS

What will audience learn from your presentation?

  • The study results will help determine the risk factors common to Filipino people at high risk for drug resistant tuberculosis.
  • The study results will help improve the existing policies and tailor fit to the Filipino people.
  • Tuberculosis has been a global health concern in the world and Philippines is among the 30 countries with high TB burden. The results of the study may help determine risk factors that could affect the treatment outcome of drug resistant TB patients, and this will help improve the management to further enhance the treatment success rates.
  • This study establishes the baseline data for Filipinos with Drug resistant TB and can be implemented in a wider scale.


Dr. Lester Jay Corsame finished his residency training in Internal Medicine at Zamboanga City Medical Center. He received his diplomate degree in 2022. Currently, he is under deployment program of the Department of Health to the rural areas.